Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

C. Pelser, J.M. Middeldorp, S.M. Mbulaiteye, C. Lauria, E. Viviano, N. Romano, F. Vitale, J.J. Goedert

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)18
Number of pages5
JournalInfectious Agents and Cancer
Publication statusPublished - 2010

Cite this